Salesforce stock slips after-hours to end 2025 as focus turns to Agentforce AI and Feb. 25 earnings

Salesforce stock slips after-hours to end 2025 as focus turns to Agentforce AI and Feb. 25 earnings

NEW YORK, December 31, 2025, 19:03 ET — After-hours

  • Salesforce fell 0.4% to $264.91, little changed in extended trade
  • Wall Street ended the year’s final session lower, led by tech weakness
  • Investors now look to Agentforce AI traction and Salesforce’s next earnings date

Salesforce, Inc. shares ended down 0.4% on Wednesday and hovered near $264.91 in after-hours trading, as the cloud software maker closed out 2025’s final session on a subdued note. The stock traded between $264.44 and $266.12 during the session.

The late drift underscored how thin year-end liquidity can magnify moves in large-cap technology names, even without fresh company news.

For Salesforce, the timing matters because investors are resetting exposure ahead of 2026, when spending on enterprise software and new AI features is expected to be under sharper scrutiny.

A Yahoo Finance report earlier on Wednesday highlighted a 330% year-on-year jump in annual recurring revenue for Salesforce’s Agentforce offering, to about $540 million. Annual recurring revenue is the run-rate value of subscription contracts. 1

Salesforce sells customer relationship management software — tools that help companies track sales leads and manage customer service — and has been pushing customers toward add-on AI features, including “AI agents” designed to take actions such as drafting emails or updating records.

Wall Street ended the year’s final session lower, with the S&P 500 down 0.74% and the Nasdaq off 0.76%, Reuters reported, as tech shares weighed on benchmarks. “I do not expect that the last few days will have so much bearing on the performance of the next year,” said Giuseppe Sette, co-founder and president of Reflexivity, citing profit-taking when liquidity was low. Markets are closed Thursday for New Year’s Day. 2

In enterprise software, Microsoft fell 0.8%, Oracle slid 1.2% and ServiceNow dropped 0.7%, keeping pressure on the group.

Salesforce last updated investors on Dec. 3, when it raised its fiscal 2026 revenue and adjusted profit forecasts on stronger demand for its AI agent platform, Reuters reported. 3

That guidance sets the bar for 2026, when investors will look for AI-driven growth to show up in paid subscriptions while margins hold up.

The next major checkpoint is the company’s quarterly report expected on Feb. 25, 2026 after the bell, according to Yahoo Finance’s earnings calendar, with analysts looking for about $3.05 per share in profit.

Until then, traders are likely to focus on updates around Agentforce deal wins, renewals and operating margins, along with any new partnerships that broaden Salesforce’s reach in enterprise AI.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight
Previous Story

Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight

Sidus Space stock swings after-hours as $16.2 mln share sale and new 13G stake keep SIDU in focus
Next Story

Sidus Space stock swings after-hours as $16.2 mln share sale and new 13G stake keep SIDU in focus

Go toTop